Our Business

Diagnostic drugs

Nippon Kayaku provides diagnostics pertaining to tumor markers, which are useful for diagnosing cancer and judging the therapeutic effects and prognoses in the pharmaceuticals business.

Nippon Kayaku also produces and sells a product as a marker of blood sugar contrel (GlycoMark) used for diabetes. This product has been approved by the U.S. Food and Drug Administration (FDA) and are used in foreign countries. Thus, Nippon Kayaku has been deploying its business all over the world.

Inquiries about this product

Diagnostics Division
Inquiry form

Corporate Vision
Our Business
Corporate Information
Global Netowork
Investor Relations